Enzymatic biosynthesis of β-lactam antibiotics

Swati Srivastava,Reeta Bhati,Rajni Singh

Biotechnology of Microbial Enzymes(2023)

引用 0|浏览3
暂无评分
摘要
β-Lactam antibiotics (BLAs) are bactericidal drugs inhibiting bacterial growth by obstructing penicillin-binding proteins (PBPs) responsible for the transpeptidation/cross-linking process during cell wall biosynthesis. The β-lactam ring, a four-membered lactam, is a cyclic amide having a nitrogen atom coupled with the β-carbon of the carbonyl ring. It consists of four major classes, that is, penicillin derivatives, cephalosporins, monobactams, and carbapenems. The drugs that constitute >60% of the antimicrobials are from naturally occurring β-lactams. It represents one of the premier categories of antibiotics advised for antibacterial treatment even today after five decades of its discovery. Most of the β-lactams are produced via fermentation or modification of fermented intermediates except for carbapenems and aztreonam. The β-lactam biosynthesis generally follows nonoxidative reactions. However, enzymatic synthesis is also important by using enzymes such as 2-oxoglutarate (2OG)-dependent oxygenases, isopenicillin N synthase, clavaminic acid synthase, β-lactam synthetases, nonribosomal peptide synthetases, etc. The chapter discusses the knowledge of the enzymology leading to the biosynthesis of BLAs and their effective derivatives.
更多
查看译文
关键词
enzymatic biosynthesis,antibiotics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要